Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.116230
Revised: November 11, 2025
Accepted: December 8, 2025
Published online: January 15, 2026
Processing time: 68 Days and 1 Hours
Correction to “Liu QQ, Li YD, Chen JX, Zhang LL, Guan RC, Zhao W, Meng LY. Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization. World J Gastrointest Oncol 2025; 17(6): 103198 PMID: 40547171 DOI: 10.4251/wjgo.v17.i6.103198”. The funding number listed in the "Supported by" section of this article needs to be corrected.
Core Tip: This manuscript is to add a correction note to “Liu QQ, Li YD, Chen JX, Zhang LL, Guan RC, Zhao W, Meng LY. Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization. World J Gastrointest Oncol 2025; 17(6): 103198 PMID: 40547171
- Citation: Liu QQ, Li YD, Chen JX, Zhang LL, Guan RC, Zhao W, Meng LY. Correction to “Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization”. World J Gastrointest Oncol 2026; 18(1): 116230
- URL: https://www.wjgnet.com/1948-5204/full/v18/i1/116230.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i1.116230
This is a correction to:
| 1. | Liu QQ, Li YD, Chen JX, Zhang LL, Guan RC, Zhao W, Meng LY. Prognostic value of preoperative fibrinogen, neutrophil-to-lymphocyte ratio, serum alpha-fetoprotein, and prealbumin for patients with primary liver cancer undergoing transarterial chemoembolization. World J Gastrointest Oncol. 2025;17:103198. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 1] [Cited by in RCA: 1] [Article Influence: 1.0] [Reference Citation Analysis (5)] |
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
